GlassScriptPhysician profile
Donald R Tyler
NPI 1134120272
$4,544.94
in general payments reported to CMS, 2019-2025
19 companies · $44.49 in 2025
The $44.49 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,534 · 2020: $1,631 · 2021: $227 · 2022: $33.99 · 2023: $41.93 · 2024: $33.32 · 2025: $44.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $3,711.88 | 2019-2020 | |
| Orthofix Medical, INC. | $199.96 | 2019 | |
| Emd Serono, INC. | $119.43 | 2019-2021 | |
| Zavation Medical Products, LLC | $95.60 | 2021 | |
| Precision Spine, INC. | $78.41 | 2020 | |
| Medtronic, INC. | $42.29 | 2021-2024 | Intellis Adaptivestim |
| Abbvie INC. | $38.40 | 2023-2025 | Botox |
| Novartis Pharmaceuticals Corporation | $32.71 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $31.35 | 2019 | |
| Greenwich Biosciences, INC. | $27.00 | 2021 | |
| 4web, INC. | $24.39 | 2023 | Spine Truss System |
| Mallinckrodt Hospital Products INC. | $23.63 | 2025 | Acthar |
| Ucb, INC. | $21.64 | 2021 | |
| Jazz Pharmaceuticals INC. | $19.02 | 2022 | |
| Silk Road Medical, INC. | $18.03 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adamas Pharmaceuticals, INC. | $17.49 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.36 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.34 | 2019 | |
| Amgen INC. | $14.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Tyler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.